GeneDx (WGS) PT Raised to $74 at Guggenheim
Tweet
Share
E-mailGet Alerts WGS Hot Sheet
Price: $79.15 --0%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Guggenheim analyst Subbu Nambi raised the price target on GeneDx (NASDAQ: WGS) to $74.00 (from $70.00) while maintaining a Buy rating.
You May Also Be Interested In
- GeneDx launches online exome testing access for pediatric patients
- Globant S.A. (GLOB) PT Lowered to $50 at Guggenheim
- Lithium Americas Corp. (LAC) PT Lowered to $4 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
